EMA OKs First Therapy for Non-Cystic Fibrosis Bronchiectasis – Medscape

  1. EMA OKs First Therapy for Non-Cystic Fibrosis Bronchiectasis  Medscape
  2. Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 October 2025  European Medicines Agency
  3. Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia  Yahoo Finance
  4. EU regulator backs first-ever treatment for bronchiectasis  Investing.com
  5. Insmed Incorporated CHMP Recommends EU Approval of Brinsupri (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis  MarketScreener

Continue Reading